Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
In this study, a series of self-assembled polyionic complexes (PICs) were prepared via electrostatic attraction between protamine sulfate (PS) and poly(L-aspartic acid) (PASP) or doxorubicin (DOX)-conjugated PASP (DOX-PASP). The size of the PICs measured by Nano-ZS ZEN3600 was around 200-300 nm at different weight ratios of PS/PASP. Transmission electron microscopy (TEM) showed that PS/PASP PICs displayed a regular spherical shape and no aggregation was observed. The cytotoxicity study indicated that the PICs did not exhibit apparent cytotoxicity in comparison with that of 25 kDa polyethylenimine (PEI). Gel retardation assay indicated that the PICs were able to bind DNA completely when weight ratio of PS/PASP was higher than 2:1. Luciferase assay and green fluorescent protein (GFP) detection were used to confirm that the PICs could be used as efficient non-viral gene vectors and they exhibited comparable transfection efficiency with the one of 25 kDa PEI. Furthermore, confocal laser scanning microscopy as well as suppression activity of DOX-conjugated PICs (DOX-PICs) showed that they could quickly release the loaded DOX into HeLa cells, indicating that PICs can be also used as carriers for combined delivery of drug and gene.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.biomaterials.2008.11.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cholesterol-Conjugated Polyion Complex Nanoparticles for Combination Delivery of Hydrophobic Paclitaxel and Hydrophilic miR-34a for Colon Cancer Therapy.
Int J Mol Sci
August 2025
BK21 FOUR Program in Biomedical Science and Engineering, Department of Biomedical Science, Inha University College of Medicine, Incheon 22332, Republic of Korea.
In recent years, combination chemotherapy with therapeutic nucleic acids has emerged as a promising strategy to enhance the effectiveness of cancer therapy. However, developing an effective co-delivery system to simultaneously transport both chemotherapeutic drugs and nucleic acids remains challenging. Herein, we fabricated cholesterol-conjugated polyion complex nanoparticles (PCNs) for combination delivery of hydrophobic paclitaxel (PTX) and hydrophilic miR-34a.
View Article and Find Full Text PDFEnhanced Accumulation of Heteroduplex Oligonucleotides in Dystrophin-Deficient Skeletal Muscles by Single Oligonucleotide-Loaded Unit Polyion Complexes.
ACS Omega
August 2025
Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Efficient delivery of oligonucleotide drugs to muscle tissues remains a significant challenge in nanomedicine and oligonucleotide therapeutics. A primary obstacle is the blood-muscle barrier, a continuous endothelium within muscle tissues that impedes the extravasation of conventional nanomedicines, typically ranging from a few tens of nanometers to 100 nm. To address this challenge, we developed an ultrasmall oligonucleotide nanomedicine, termed the unit polyion complex (uPIC), using a single molecular oligonucleotide with Y-shaped block catiomers.
View Article and Find Full Text PDFSilica-coated polyion complexes for enhanced pulmonary messenger RNA delivery with optimized silica layer stability.
J Control Release
August 2025
Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan. Electronic address: miyat
Pulmonary administration of messenger RNA (mRNA) therapeutics holds great promise for the treatment of lung diseases, as it facilitates local drug accumulation while reducing systemic side effects. However, the fragile nature and inefficient cellular internalization of mRNA in the respiratory epithelium are inherent bottlenecks to mRNA therapy. Although various nanomedicines, mainly lipid and polymeric nanoparticles, have been explored to protect mRNA payloads, their stability in harsh bioenvironments remains severely limited.
View Article and Find Full Text PDFEnhanced cancer immunotherapy via synergistic action of NO-Donor nanoparticles (Nano) and PD-1 antibody.
Sci Technol Adv Mater
July 2025
Department of Materials Science, Faculty of Pure and Applied Sciences, University of Tsukuba, Tsukuba Ibaraki, Japan.
This study explores the synergistic potential of PEG-b-P(L-Arg)-based polyion complex micelles (Nanos) combined with an immune checkpoint inhibitor (PD-1 antibody) for cancer immunotherapy. Comprehensive experiments, including micelle preparation, anti-tumor activity evaluation, nitric oxide (NO) quantification, and immunofluorescence analysis, revealed significant insights. Nanos exhibited a biphasic effect on tumor growth: high doses inhibited tumor growth through NO generated from liberated Arg, whereas low doses promoted tumor progression.
View Article and Find Full Text PDFFrom Nano to Micro Polyion Complex Vesicles: Synthetic Cells with Membrane-Embedded Enzymes.
ACS Appl Mater Interfaces
August 2025
Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, Jenaro de la Fuente s/n, Santiago de Compostela 15782, Spain.
Synthetic cells are emerging as cornerstone in our understanding of prebiotic forms of early life and the development of therapeutics. Although several types of vesicles have been proposed for this purpose, their development is often hampered by limited membrane permeability. On the other hand, polyion complex vesicles (PICsomes) with a high permeability for small molecules suffer from a small size (typically sub-200 nm) and low encapsulation efficiency of enzymes (less than 4%).
View Article and Find Full Text PDF